FDA Drug Recalls

Recalls / Class II

Class IID-0897-2021

Product

ceFAZolin 3 G in 0.9% Sodium Chloride, 115 mL Bag for Injection, Sterile Product, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC: 71139-7153-1

Affected lot / code info
Lot, expiry: 20210722CEF-2, exp 09/20/2021; 20210728CEF-1, exp 09/26/2021

Why it was recalled

Lack of sterility assurance.

Recalling firm

Firm
IntegraDose Compounding Services LLC
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
719 Kasota Ave Se, N/A, Minneapolis, Minnesota 55414-2842

Distribution

Quantity
589 bags
Distribution pattern
NH, MA, MN

Timeline

Recall initiated
2021-09-17
FDA classified
2021-09-30
Posted by FDA
2021-10-06
Terminated
2022-10-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0897-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.